Olmesartan medoxomil (Macleods Pharmaceuticals Limited)
Welcome to the PulseAid listing for the Olmesartan medoxomil drug offered from Macleods Pharmaceuticals Limited. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Macleods Pharmaceuticals Limited |
NON-PROPRIETARY NAME: | Olmesartan medoxomil |
SUBSTANCE NAME: | OLMESARTAN MEDOXOMIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-04-25 |
END MARKETING DATE: | 0000-00-00 |
Olmesartan medoxomil HUMAN PRESCRIPTION DRUG Details:
Item Description | Olmesartan medoxomil from Macleods Pharmaceuticals Limited |
LABELER NAME: | Macleods Pharmaceuticals Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-04-25 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 33342-178_24e308cc-7cec-4054-9627-66f743ed71b0 |
PRODUCT NDC: | 33342-178 |
APPLICATION NUMBER: | ANDA204814 |
Other OLMESARTAN MEDOXOMIL Pharmaceutical Manufacturers / Labelers: